Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Moderna (MRNA) Tops Q2 EPS by 32c
August 3, 2023 6:34 AM EDT(Updated - August 3, 2023 7:00 AM EDT)
Moderna (NASDAQ: MRNA) reported Q2 EPS of ($3.62), $0.32 better than the analyst estimate of ($3.94). Revenue for the quarter came in at $344 million versus the consensus estimate of $307.65 million.
Company expecting 2023 COVID-19 vaccine sales of $6 billion to $8... More
Moderna (MRNA) Guides FY23 Covid-19 Vax Revenue of $6B-$8B
August 3, 2023 6:33 AM EDTModerna (MRNA) Guides FY23 Covid-19 Vax Revenue of $6B-$8B
... More